CS395291A3 - Anti-hypertension preparation - Google Patents

Anti-hypertension preparation

Info

Publication number
CS395291A3
CS395291A3 CS913952A CS395291A CS395291A3 CS 395291 A3 CS395291 A3 CS 395291A3 CS 913952 A CS913952 A CS 913952A CS 395291 A CS395291 A CS 395291A CS 395291 A3 CS395291 A3 CS 395291A3
Authority
CS
Czechoslovakia
Prior art keywords
formula
image
hypertension
preparation
hypertension preparation
Prior art date
Application number
CS913952A
Other languages
English (en)
Inventor
Cornelius Kleinbloesem
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS395291A3 publication Critical patent/CS395291A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CS913952A 1988-03-24 1991-12-20 Anti-hypertension preparation CS395291A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH111488 1988-03-24

Publications (1)

Publication Number Publication Date
CS395291A3 true CS395291A3 (en) 1992-06-17

Family

ID=4202814

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913952A CS395291A3 (en) 1988-03-24 1991-12-20 Anti-hypertension preparation

Country Status (13)

Country Link
EP (1) EP0334164B1 (cs)
JP (1) JPH01283224A (cs)
KR (1) KR890014116A (cs)
AT (1) ATE96322T1 (cs)
AU (1) AU616249B2 (cs)
CS (1) CS395291A3 (cs)
DE (1) DE58905990D1 (cs)
DK (1) DK140389A (cs)
HU (1) HU206612B (cs)
IL (1) IL89654A (cs)
MC (1) MC2019A1 (cs)
MX (1) MX9203171A (cs)
ZA (1) ZA892061B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409631D1 (de) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW11586A1 (en) * 1985-07-01 1987-12-30 Hoffmann La Roche Bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat

Also Published As

Publication number Publication date
KR890014116A (ko) 1989-10-21
JPH01283224A (ja) 1989-11-14
MC2019A1 (fr) 1990-02-23
ATE96322T1 (de) 1993-11-15
DK140389D0 (da) 1989-03-21
HUT50281A (en) 1990-01-29
AU616249B2 (en) 1991-10-24
IL89654A (en) 1993-06-10
DK140389A (da) 1989-09-25
DE58905990D1 (de) 1993-12-02
AU3145689A (en) 1989-09-28
HU206612B (en) 1992-12-28
MX9203171A (es) 1992-07-01
ZA892061B (en) 1989-11-29
EP0334164A3 (en) 1990-05-23
EP0334164A2 (de) 1989-09-27
EP0334164B1 (de) 1993-10-27
IL89654A0 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
TW218874B (cs)
AU2327592A (en) Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
AU1033292A (en) Indole piperazine derivatives and pharmaceutical preparations containing such derivatives
AU7679587A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof
MX9300662A (es) Derivados fosfonooxi y carbonato de taxol
IL89691A0 (en) Pharmaceutical compositions containing bis(3,4-dihydro-2h-1-benzopyran)derivatives for lowering blood pressure,certain such novel compounds and their preparation
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
DE59000750D1 (de) Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate.
GB9206244D0 (en) Cytotoxic compound from a marine sponge
AU4536389A (en) Anti-antherosclerotic diaryl compounds
IL84844A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
WO1991001958A3 (de) 11β-ARYL-GONA-4,9-DIEN-3-ONE
CS395291A3 (en) Anti-hypertension preparation
AU1643592A (en) Novel compound and use of the same as medicine
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
NO870834D0 (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
AR243159A1 (es) Procedimiento de preparacion de acido 1-(3-mercapto-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico o sus sales farmaceuticamente aceptables.
GB1505518A (en) Pyrazole derivatives
AU8057687A (en) Pharmaceutical composition for use against hypertension and congestive heart failure
IL105599A0 (en) Enantiomers derived from(s)-2-amino-2(3,4-dichlorobenzyl)-1-propanol and pharmaceutical compositions containing same
GB8823283D0 (en) Pharmaceutical composition for use against hypertension & congestive heart failure